Chemotherapy in advanced ovarian cancer.
D000230:Adenocarcinoma / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology; D000328:Adult; D000368:Aged; D000477:Alkylating Agents / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D003536:Cystadenocarcinoma / Q000188:drug therapy* / Q000473:pathology; D003537:Cystadenoma / Q000188:drug therapy* / Q000473:pathology; D004359:Drug Therapy, Combination; D004715:Endometriosis / Q000188:drug therapy* / Q000473:pathology; D005260:Female; D005472:Fluorouracil / Q000627:therapeutic use; D006801:Humans; D010535:Laparoscopy; D008649:Mesonephroma / Q000188:drug therapy* / Q000473:pathology; D008727:Methotrexate / Q000627:therapeutic use; D008875:Middle Aged; D010051:Ovarian Neoplasms / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology / Q000532:radiotherapy; D010166:Palliative Care; D011859:Radiography
D000477:Alkylating Agents; D000970:Antineoplastic Agents; D005472:Fluorouracil; D008727:Methotrexate